Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brian, the pharmaceutical compositions comprising them and their use in the treatment of Parkinson's disease

Details for Australian Patent Application No. 2008212039 (hide)

International Classifications

Event Publications

25 September 2008 Complete Application Filed

9 October 2008 Application Open to Public Inspection

Published as AU-A-2008212039

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.